These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 22003423)

  • 1. Prenatal tobacco, marijuana, stimulant, and opiate exposure: outcomes and practice implications.
    Minnes S; Lang A; Singer L
    Addict Sci Clin Pract; 2011 Jul; 6(1):57-70. PubMed ID: 22003423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Illicit drug use and neonatal outcomes: a critical review.
    Schempf AH
    Obstet Gynecol Surv; 2007 Nov; 62(11):749-57. PubMed ID: 17925048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of maternal and neonatal substance abuse problems.
    Finnegan L
    NIDA Res Monogr; 1988; 90():177-82. PubMed ID: 3151924
    [No Abstract]   [Full Text] [Related]  

  • 4. Maternal Exposure and Neonatal Effects of Drugs of Abuse.
    Barry JM; Birnbaum AK; Jasin LR; Sherwin CM
    J Clin Pharmacol; 2021 Aug; 61 Suppl 2():S142-S155. PubMed ID: 34396555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal alcohol and drug exposures in adoption.
    Davies JK; Bledsoe JM
    Pediatr Clin North Am; 2005 Oct; 52(5):1369-93, vii. PubMed ID: 16154468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Consequences of tobacco, cocaine and cannabis consumption during pregnancy on the pregnancy itself, on the newborn and on child development: A review].
    Lamy S; Laqueille X; Thibaut F
    Encephale; 2015 Jun; 41 Suppl 1():S13-20. PubMed ID: 25439854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal substance exposure: neurobiologic organization at 1 month.
    Conradt E; Sheinkopf SJ; Lester BM; Tronick E; LaGasse LL; Shankaran S; Bada H; Bauer CR; Whitaker TM; Hammond JA;
    J Pediatr; 2013 Oct; 163(4):989-94.e1. PubMed ID: 23743094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infants of drug-dependent mothers.
    Jansson LM; Velez ML
    Pediatr Rev; 2011 Jan; 32(1):5-12; quiz 12-3. PubMed ID: 21196501
    [No Abstract]   [Full Text] [Related]  

  • 9. Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome.
    Gray TR; Choo RE; Concheiro M; Williams E; Elko A; Jansson LM; Jones HE; Huestis MA
    Addiction; 2010 Dec; 105(12):2151-9. PubMed ID: 20854338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cocaine exposure and developmental outcome from birth to 6 months.
    Behnke M; Eyler FD; Garvan CW; Wobie K; Hou W
    Neurotoxicol Teratol; 2002; 24(3):283-95. PubMed ID: 12009484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal methamphetamine exposure and childhood behavior problems at 3 and 5 years of age.
    LaGasse LL; Derauf C; Smith LM; Newman E; Shah R; Neal C; Arria A; Huestis MA; DellaGrotta S; Lin H; Dansereau LM; Lester BM
    Pediatrics; 2012 Apr; 129(4):681-8. PubMed ID: 22430455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal neurobehavioral and neuroanatomic correlates of prenatal cocaine exposure. Problems of dose and confounding.
    Frank DA; Augustyn M; Zuckerman BS
    Ann N Y Acad Sci; 1998 Jun; 846():40-50. PubMed ID: 9668396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obstetric and neonatal effects of drugs of abuse.
    Levy M; Koren G
    Emerg Med Clin North Am; 1990 Aug; 8(3):633-52. PubMed ID: 2201525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal tobacco and marijuana co-use: Impact on newborn neurobehavior.
    Stroud LR; Papandonatos GD; McCallum M; Kehoe T; Salisbury AL; Huestis MA
    Neurotoxicol Teratol; 2018; 70():28-39. PubMed ID: 30266574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marijuana, Spice 'herbal high', and early neural development: implications for rescheduling and legalization.
    Psychoyos D; Vinod KY
    Drug Test Anal; 2013 Jan; 5(1):27-45. PubMed ID: 22887867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview and epidemiology of substance abuse in pregnancy.
    Wendell AD
    Clin Obstet Gynecol; 2013 Mar; 56(1):91-6. PubMed ID: 23314721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking during pregnancy and newborn neurobehavior.
    Law KL; Stroud LR; LaGasse LL; Niaura R; Liu J; Lester BM
    Pediatrics; 2003 Jun; 111(6 Pt 1):1318-23. PubMed ID: 12777547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal methadone exposure and child developmental outcomes in 2-year-old children.
    Levine TA; Davie-Gray A; Kim HM; Lee SJ; Woodward LJ
    Dev Med Child Neurol; 2021 Sep; 63(9):1114-1122. PubMed ID: 33462809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal and longer term management following substance misuse in pregnancy.
    Mactier H
    Early Hum Dev; 2013 Nov; 89(11):887-92. PubMed ID: 24113212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns in sleep-wakefulness in three-month old infants exposed to methadone or buprenorphine.
    Sarfi M; Martinsen H; Bakstad B; Røislien J; Waal H
    Early Hum Dev; 2009 Dec; 85(12):773-8. PubMed ID: 19931991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.